Women with hormone receptor (HR) negative first tumors have twice as much risk for developing a second breast cancer as women with HR-positive tumors, according to a study published online July 9 in the Journal of the National Cancer Institute. Christina A. Clarke, Ph.D., of the Northern California Cancer Center in Fremont, Calif.
More...